Integrated temporal profiling of iPSCs-derived motor neurons from ALS patients carrying C9orf72, FUS, TARDBP, and SOD1 mutations

Guoming Ma,Congcong Xia,Boyu Lyu,Jie Liu,Fang Luo,Mingfeng Guan,Junying Wang,Li Sun,Lin Zhang,Yan Chen,Yingwei Mao,Guoqiang Yu,Wenyuan Wang

DOI: https://doi.org/10.1101/2024.10.15.618602

2024-10-18

Abstract:Amyotrophic Lateral Sclerosis (ALS) is a lethal neurodegenerative disease that damages motor neurons in the central nervous system, causing progressive muscle weakness that ultimately leads to death. However, its underlying mechanisms still need to be fully understood, particularly the heterogeneity and similarity between various gene mutants during disease progression. In this study, we conducted temporal RNA-seq profiling in human induced pluripotent stem cells (hiPSCs) and iPSC-derived motor neurons (iMNs) carrying the C9orf72, FUS, TARDBP, and SOD1 mutations from both ALS patients and healthy individuals. We discovered dysregulated gene expression and alternative splicing (AS) throughout iMN development and maturation, and ALS iMNs display enrichment of cytoskeletal defects and synaptic alterations from premature stage to mature iMNs. Our findings indicate that synaptic gene dysfunction is the common molecular hallmark of fALS, which might result in neuronal susceptibility and progressive motor neuron degeneration. Analysis of upstream splicing factors revealed that differentially expressed RNA-binding proteins (RBPs) in ALS iMNs may cause abnormal AS events, suggesting the importance of studying RBP defects in ALS research. Overall, our research provides a comprehensive and valuable resource for gaining insights into the shared mechanisms of ALS pathogenesis during motor neuron development and maturation in iMN models.

Neuroscience

What problem does this paper attempt to address?

The problem this paper attempts to address is: Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease that primarily affects motor neurons in the central nervous system, leading to progressive muscle weakness and ultimately death. However, its underlying mechanisms are not fully understood, especially the heterogeneity and similarity of different gene mutations in the disease progression. To better understand these mechanisms, the study conducted a time-series RNA sequencing analysis using human induced pluripotent stem cells (hiPSCs) and iPSC-derived motor neurons (iMNs) from ALS patients carrying C9orf72, FUS, TARDBP, and SOD1 mutations, as well as healthy individuals. The main objectives of the study include: 1. **Reveal changes in gene expression and alternative splicing**: Investigate the changes in gene expression and alternative splicing (AS) during iMN development and maturation. 2. **Identify early-stage molecular markers**: Determine the enrichment of cytoskeletal defects and synaptic alterations in ALS iMNs from early to mature stages. 3. **Explore the role of RNA-binding proteins**: Analyze upstream splicing factors, particularly differentially expressed RNA-binding proteins (RBPs), to understand how they lead to abnormal AS events. 4. **Identify common molecular mechanisms**: Investigate the common molecular mechanisms of synaptic function-related genes and pathways that may be regulated by multiple ALS pathogenic risk factors, leading to neuronal vulnerability and progressive degeneration. Through these studies, the authors hope to provide a comprehensive and valuable resource for understanding the pathogenesis of ALS, particularly in the shared mechanisms during motor neuron development and maturation.

Integrated temporal profiling of iPSCs-derived motor neurons from ALS patients carrying C9orf72, FUS, TARDBP, and SOD1 mutations

Single cell RNA sequencing in isogenic FUS and TARDBP mutant ALS lines reveals early mitochondrial dysfunction as a common pathway in motor neurons

Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells

RNA-Seq Profiling of Spinal Cord Motor Neurons from a Presymptomatic SOD1 ALS Mouse

Neuromuscular Organoids Model Spinal Neuromuscular Pathologies in C9orf72 Amyotrophic Lateral Sclerosis

Neuromuscular dysfunction in patient-derived FUS -ALS iPSC model via axonal downregulation of neuromuscular junction proteins

Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism

Integrative Genetic and Single Cell RNA Sequencing Analysis Provides New Clues to the Amyotrophic Lateral Sclerosis Neurodegeneration.

Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability

Neural Differentiation and spinal cord organoid generation from induced pluripotent stem cells (iPSCs) for ALS modelling and inflammatory screening

An integrative miRNA-mRNA expression analysis identifies miRNA signatures associated with SOD1 and TARDBP patient-derived motor neurons

Identifying Candidate Genes Associated with Sporadic Amyotrophic Lateral Sclerosis Via Integrative Analysis of Transcriptome-Wide Association Study and Messenger RNA Expression Profile

Key Molecules and Pathways Underlying Sporadic Amyotrophic Lateral Sclerosis: Integrated Analysis on Gene Expression Profiles of Motor Neurons

Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons

Modeling sporadic juvenile ALS in iPSC-derived motor neurons explores the pathogenesis of FUSR503fs mutation

Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls

Transcriptional modulation unique to vulnerable motor neurons predicts ALS across species and SOD1 mutations

Cellular and axonal transport phenotypes due to the C9ORF72 HRE in iPSC motor and sensory neurons

KIF1A, R1457Q, and P1688L Mutations Induce Protein Abnormal Aggregation and Autophagy Impairment in iPSC-Derived Motor Neurons

C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca2+-permeable AMPA receptor-mediated excitotoxicity

Modeling ALS with Ipscs Reveals That Mutant SOD1 Misregulates Neurofilament Balance in Motor Neurons.